Literature DB >> 1318370

Relationship between benzodiazepine receptor occupancy and potentiation of gamma-aminobutyric acid-stimulated chloride flux in vitro of four ligands of differing intrinsic efficacies.

M Facklam1, P Schoch, W E Haefely.   

Abstract

Intrinsic efficacy is the inherent ability of a ligand to induce the conformational change of its receptor that is required to transduce the event of signal recognition into a physiologically relevant response. Relating fractional receptor occupancy to fractional effect is an indirect but reliable way to assess relative intrinsic efficacy. The receptor studied was the benzodiazepine receptor (BZR), a modulatory site on the gamma-aminobutyric acidA (GABAA) receptor-chloride channel. The relationship between fractional BZR occupancy, as assessed by inhibition of [3H]flumazenil binding, and potentiation of GABA-stimulated 36Cl- influx into membrane vesicles of rat cerebral cortex was evaluated for four ligands under identical experimental conditions. Triazolam and the quinolizinone Ro 19-8022 potentiated the effect of GABA maximally by nearly 50%, diazepam by about 40% and bretazenil by approximately 20%. Potentiation of GABA-stimulated 36Cl- flux by 25% was observed at about 35% BZR occupancy for diazepam, about 45% for triazolam and about 95% for Ro 19-8022. Bretazenil did not produce 25% potentiation even at receptor saturation. Although the curves relating fractional BZR occupancy to GABA potentiation were hyperbolic and nearly superimposable for triazolam and diazepam, those for Ro 19-8022 and bretazenil displayed parabolic characteristics by inducing an effect only at very high BZR occupancy, reflecting the partial agonistic profile of the latter two compounds. The rank order of relative intrinsic efficacy determined in this study was: triazolam congruent to diazepam much greater than Ro 19-8022 greater than bretazenil.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1318370

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  9 in total

1.  Differential behavioral effects of low efficacy positive GABAA modulators in combination with benzodiazepines and a neuroactive steroid in rhesus monkeys.

Authors:  Lance R McMahon; Charles P France
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

2.  Self-administration of bretazenil under progressive-ratio schedules: behavioral economic analysis of the role intrinsic efficacy plays in the reinforcing effects of benzodiazepines.

Authors:  Stephanie C Licata; James K Rowlett
Journal:  Drug Alcohol Depend       Date:  2010-08-30       Impact factor: 4.492

Review 3.  The diversity of GABAA receptors. Pharmacological and electrophysiological properties of GABAA channel subtypes.

Authors:  W Hevers; H Lüddens
Journal:  Mol Neurobiol       Date:  1998-08       Impact factor: 5.590

4.  Discriminative stimulus effects of L-838,417 (7-tert-butyl-3-(2,5-difluoro-phenyl)-6-(2-methyl-2H-[1,2,4]triazol-3-ylmethoxy)-[1,2,4]triazolo[4,3-b]pyridazine): role of GABA(A) receptor subtypes.

Authors:  Stephanie C Licata; Donna M Platt; Daniela Rüedi-Bettschen; John R Atack; Gerard R Dawson; Michael L Van Linn; James M Cook; James K Rowlett
Journal:  Neuropharmacology       Date:  2009-10-22       Impact factor: 5.250

5.  Comparison of several benzodiazepine receptor ligands in two models of anxiolytic activity in the mouse: an analysis based on fractional receptor occupancies.

Authors:  G H Jones; C Schneider; H H Schneider; J Seidler; B J Cole; D N Stephens
Journal:  Psychopharmacology (Berl)       Date:  1994-03       Impact factor: 4.530

6.  Discriminative stimulus effects of alpidem, a new imidazopyridine anxiolytic.

Authors:  D J Sanger; B Zivkovic
Journal:  Psychopharmacology (Berl)       Date:  1994-01       Impact factor: 4.530

7.  Changes in relative potency among positive GABA(A) receptor modulators upon discontinuation of chronic benzodiazepine treatment in rhesus monkeys.

Authors:  Lance R McMahon; Martin A Javors; Charles P France
Journal:  Psychopharmacology (Berl)       Date:  2007-01-24       Impact factor: 4.415

8.  Lack of generalisation between the GABAA receptor agonist, gaboxadol, and allosteric modulators of the benzodiazepine binding site in the rat drug discrimination procedure.

Authors:  Signe Michelsen; Connie Sánchez; Bjarke Ebert
Journal:  Psychopharmacology (Berl)       Date:  2007-03-15       Impact factor: 4.415

Review 9.  Flavonoids as GABAA receptor ligands: the whole story?

Authors:  Cristina Wasowski; Mariel Marder
Journal:  J Exp Pharmacol       Date:  2012-02-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.